ZENAS BIOPHARMA INC

$ZBIO
Smart money positioned

7 of the Top-200 alpha managers hold $ZBIO as of the latest 13F snapshot.

13F holders
130
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

7 holders · Q1 2026

$ZBIO is held by 7 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 21.80%, with an average of 3.13% of portfolio. Largest holder: Enavate Sciences GP, LLC at 21.80%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 130 · Source: 13F-HR
01
Eclipse Ventures, LLC
10.76% of portfolio
5,037,854 sh
02
Litman Gregory Wealth Management LLC
0.01% of portfolio
4,868,000 sh
03
Gotham Asset Management, LLC
4.47% of portfolio
4,023,219 sh
04
ADAR1 Capital Management, LLC
21.80% of portfolio
3,919,159 sh
05
Enavate Sciences GP, LLC
25.50% of portfolio
3,761,359 sh
06
TB Capital Gestao de Recursos Ltda.
0.01% of portfolio
3,231,714 sh
07
Fernbridge Capital Management LP
0.18% of portfolio
2,548,444 sh
08
Fairmount Funds Management LLC
3.78% of portfolio
1,892,806 sh
09
New England Professional Planning Group Inc.
20.40% of portfolio
1,838,482 sh
10
Axa S.a.
1,470,923 sh
See all 130 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $ZBIO in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $ZBIO in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 07:00 UTC.